Enteropathy-associated T-cell lymphoma screening: Difference between revisions
Nima Nasiri (talk | contribs) |
Nima Nasiri (talk | contribs) |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AS}} | {{CMG}}; {{AE}} {{AS}} | ||
==Overview== | ==Overview== | ||
Enteropathy-associated T cell lymphoma is a very rare but aggressive disease, an extranodal form of non-Hodgkin lymphoma which has two subtypes, type I is associated with celiac disease and more common in the western population, type II is more common in Asian countries. | Enteropathy-associated T cell lymphoma is a very rare but aggressive disease, an extranodal form of non-Hodgkin lymphoma which has two subtypes, type I is associated with celiac disease and more common in the western population, type II is more common in Asian countries. | ||
==Screening== | ==Screening== | ||
Revision as of 20:33, 19 December 2018
|
Enteropathy-associated T-cell lymphoma Microchapters |
|
Differentiating Enteropathy-associated T-cell lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Enteropathy-associated T-cell lymphoma screening On the Web |
|
American Roentgen Ray Society Images of Enteropathy-associated T-cell lymphoma screening |
|
Enteropathy-associated T-cell lymphoma screening in the news |
|
Risk calculators and risk factors for Enteropathy-associated T-cell lymphoma screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Enteropathy-associated T cell lymphoma is a very rare but aggressive disease, an extranodal form of non-Hodgkin lymphoma which has two subtypes, type I is associated with celiac disease and more common in the western population, type II is more common in Asian countries.
Screening
- There is insufficient evidence to recommend routine screening for enteropathy-associated T-cell lymphoma.